Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

21.82

+0.56 (2.63%)

At close: Aug 21, 2026, 4:00 PM EDT

22.10

+0.28 (1.28%)

After-hours: Aug 21, 2026, 7:41 PM EDT

Legend Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	672.9	901.9	286.7	1,278	786.03	688.94
Short-Term Investments	291.7	46.7	835.9	30.34	54.02	193.46
Trading Asset Securities	-	-	-	0.66	185.6	-
Cash & Short-Term Investments	964.6	948.6	1,123	1,309	1,026	882.4
Cash Growth	-0.30%	-15.50%	-14.22%	27.60%	16.23%	74.49%
Accounts Receivable	-	13.1	6.4	101.43	0.28	50.5
Other Receivables	198	237.2	118.7	55.63	44.24	8.04
Receivables	198	250.3	125.1	157.06	44.52	58.55
Inventory	41.5	32	23.9	19.43	10.35	1.75
Prepaid Expenses	18.5	14.6	12.3	12.23	17.33	5.72
Other Current Assets	4.8	1.6	-	0.36	1.27	1.44
Total Current Assets	1,227	1,247	1,284	1,498	1,099	949.85
Property, Plant & Equipment	448.2	401.5	201.2	189.23	160.76	140.79
Long-Term Investments	-	-	-	4.36	-	4.71
Other Intangible Assets	-	-	-	4.06	3.41	4.68
Long-Term Accounts Receivable	-	-	-	-	0.4	-
Other Long-Term Assets	75.3	85.1	185.1	153.16	67.28	19.44
Total Assets	1,751	1,734	1,670	1,849	1,331	1,119

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	77.3	83	38.6	30.66	32.89	7.04
Accrued Expenses	103.1	123	64.5	61.58	152.73	104.38
Current Portion of Long-Term Debt	156.4	319.1	-	-	-	-
Current Portion of Leases	11.8	7.4	4.8	3.18	3.56	0.91
Current Income Taxes Payable	33.7	19.2	20.7	7.2	9.77	9.49
Current Unearned Revenue	0.7	11.3	47.4	53.08	0.45	0.3
Other Current Liabilities	20.6	73.4	101.7	60.73	98.38	107.08
Total Current Liabilities	403.6	636.4	277.7	216.42	297.79	229.2
Long-Term Debt	-	-	301.2	281.33	260.93	120.46
Long-Term Leases	110	87.2	44.6	44.17	20.04	1.59
Long-Term Unearned Revenue	-	-	6.1	55.27	7.66	1.87
Other Long-Term Liabilities	7.7	8	-	0.06	0.23	0.4
Total Liabilities	521.3	731.6	629.6	597.24	586.65	353.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.1	0.1	0.1	0.04	0.03	0.03
Additional Paid-In Capital	3,015	2,750	2,696	2,637	1,657	1,261
Retained Earnings	-1,980	-1,959	-1,662	-1,485	-966.46	-520.11
Comprehensive Income & Other	194.2	210.2	6.2	98.93	53.72	24.57
Shareholders' Equity	1,230	1,002	1,041	1,251	744.31	765.94
Total Liabilities & Equity	1,751	1,734	1,670	1,849	1,331	1,119

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	278.2	413.7	350.6	328.67	284.53	122.97
Net Cash (Debt)	686.4	534.9	772	980.05	741.12	759.43
Net Cash Growth	18.42%	-30.71%	-21.23%	32.24%	-2.41%	51.28%
Net Cash Per Share	3.70	2.90	4.22	5.57	4.66	5.39
Filing Date Shares Outstanding	193.77	184.94	183.65	181.91	165.07	154.23
Total Common Shares Outstanding	193.77	184.94	183.65	181.91	165.07	154.23
Working Capital	823.8	610.7	1,006	1,281	801.33	720.65
Book Value Per Share	6.35	5.42	5.67	6.88	4.51	4.97
Tangible Book Value	1,230	1,002	1,041	1,247	740.9	761.26
Tangible Book Value Per Share	6.35	5.42	5.67	6.86	4.49	4.94
Land	-	2.9	2.9	2.89	2.89	2.89
Buildings	-	66	65.5	65.54	45.08	16.01
Machinery	-	57.5	45	45.48	46.26	38.27
Construction In Progress	-	14.2	4.4	3.04	14.18	41.37
Leasehold Improvements	-	22.6	21.3	23.12	21.97	20.91

SEC Filings: 10-K · 10-Q